VIRMA and neoplasm: Therefore, we believe that KIAA1429 overexpression should be a predictor of poor prognosis in tumors, and low expression is a predictor of poor prognosis in non tumor diseases, and similar conclusions were obtained by bioinformatics analysis, but the related clinical data need to be further collected and analyzed.